Globalstar Announces 2020 Financial Results and Business Update
Globalstar, Inc. (NYSE American: GSAT) today announced financial and operating results for the fourth quarter
Globalstar, Inc. (NYSE American: GSAT) today announced financial and operating results for the fourth quarter
BELTSVILLE, Md., March 04, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical
Orphazyme A/SCompany announcementNo. 06/2021Company Registration No. 32266355 -Advanced arimoclomol in 4 rare disease indications; announced